Serum levels of advanced glycation end products are associated with in-stent restenosis in diabetic patients - Wikidata - wikimedia - TriplyDB

Serum levels of advanced glycation end products are associated with in-stent restenosis in diabetic patients

Serum levels of advanced glycation end products are associated with in-stent restenosis in diabetic patients

http://www.wikidata.org/entity/Q28218404

about

sameAs

Pharmacologic Approaches Against Advanced Glycation End Products (AGEs) in Diabetic Cardiovascular Disease Association of smoking with restenosis and major adverse cardiac events after coronary stenting: A meta-analysis Role of advanced glycation end products in cardiovascular disease.The clinical relevance of assessing advanced glycation endproducts accumulation in diabetes.Vascular effects of advanced glycation endproducts: Clinical effects and molecular mechanisms Advanced glycation end product (AGE)-induced hepatic stellate cell activation via autophagy contributes to hepatitis C-related fibrosis.High serum advanced glycation end-products predict coronary artery disease irrespective of arterial stiffness in diabetic patients Pathobiological role of advanced glycation endproducts via mitogen-activated protein kinase dependent pathway in the diabetic vasculopathy.Advanced Glycation End Products in the Pathogenesis of Psoriasis.

P2860

Q26782422-95BC9485-1C0D-4877-9E99-6CA4BE5AB451 Q26782715-D4D12ADA-E8AA-407B-B09B-5E244CC2CDD6 Q35929112-542C29B6-987B-4F40-BC81-B5C8BE4DD1DC Q36942530-564ACC3C-C34B-4190-A46C-31F8F4E35869 Q37636453-36DEF2E7-2C6F-491D-869F-F6BF2214DC22 Q41206326-BFB8788A-6726-4F82-8C51-29B535CF4611 Q41984177-23C8467F-7729-4522-8EBF-7DB9B7AD2CB0 Q43131789-EABB091F-C2E5-4F57-A57C-DA7B8DB08821 Q46257931-741A37F9-7256-40FE-AFA1-A38DBB9B38F0

P2860

Serum levels of advanced glycation end products are associated with in-stent restenosis in diabetic patients

http://www.wikidata.org/entity/Q28218404

description

2005 nî lūn-bûn

@nan

2005 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Serum levels of advanced glyca ...... estenosis in diabetic patients

@ast

Serum levels of advanced glyca ...... estenosis in diabetic patients

@en

Serum levels of advanced glyca ...... estenosis in diabetic patients

@nl

type

label

Serum levels of advanced glyca ...... estenosis in diabetic patients

@ast

Serum levels of advanced glyca ...... estenosis in diabetic patients

@en

Serum levels of advanced glyca ...... estenosis in diabetic patients

@nl

prefLabel

Serum levels of advanced glyca ...... estenosis in diabetic patients

@ast

Serum levels of advanced glyca ...... estenosis in diabetic patients

@en

Serum levels of advanced glyca ...... estenosis in diabetic patients

@nl

P1433

Q28218404-7EBD0E63-CA2F-4A4E-9E93-53778BCB79AA

P1476

Q28218404-DF494049-687F-4DA6-881C-2A97D4A14EF2

P2093

Q28218404-4F013B80-1BD9-423D-BA4C-684472A930BC

Q28218404-51A83FB8-8D42-4DDE-997A-D65D29A03925

Q28218404-790EC62E-93D3-4C98-A276-C5AD18142BD1

Q28218404-80050279-CB3D-4A2C-96AE-68368984FB09

Q28218404-A433F251-9871-4AC7-B777-FF671FFB2F0C

Q28218404-A9BFC1AB-284E-4F51-A93E-84E5B44C27AE

Q28218404-C258DE8F-D9C9-40B4-8C5F-4C1FEF517639

Q28218404-CD8F8067-456D-4FF8-80AB-C666C83D6D93

Q28218404-DB66AD77-F339-4D77-82B2-1B1CDBFB0BBF

Q28218404-F406CF7B-56FC-4FD0-8C86-61C4CBD1559D

P2860

Q28218404-35F4E805-7A80-44A1-A587-7E413DF8B71A

Q28218404-37F0EDBD-C65A-4891-9D70-C284018380C4

Q28218404-43D6B0AC-B456-4DAB-BACE-C5AA9FE65108

Q28218404-656FE3E2-51E4-43AC-8363-786B27D58F10

Q28218404-9FF5A942-9874-4BCA-978A-4749CB43EF09

Q28218404-A074FFAB-A8BA-4D88-BB3A-06D03CC85870

Q28218404-A6B1CAC7-0A09-44DD-BD30-67DCE53EA5E4

Q28218404-AD118651-792C-41FC-AC7B-2F82C2FA528A

Q28218404-B805B351-2D75-4DDE-9C57-74C5030ECE44

Q28218404-BF248748-51C5-41D1-A5B6-23FE292BB974

P304

Q28218404-699545DC-F9C3-486F-8D7C-A4FBCA0C77F7

P31

Q28218404-6A895398-6AD9-424C-A1B0-CAA77C006571

P356

Q28218404-CB46F9E0-9212-498B-A0EB-63BF31980373

P407

Q28218404-E1E87F61-397D-4096-BE4A-A52D2A7BB483

P433

Q28218404-211EB2AE-45E7-4822-8E0E-975F5BAF4E50

P478

Q28218404-1902B859-9095-4ED3-B0E5-3BC060C980BD

P50

Q28218404-534A7A00-0B55-4C80-871B-6B31F9584C56

Q28218404-577CCC00-B135-4558-A2C2-87E109269727

Q28218404-654590AC-E81C-4C2E-ABCC-37296EB35075

Q28218404-E565658D-413C-4960-B96D-1C913D5536E4

Q28218404-F180A503-2CEB-4F3F-A953-E05709BFDA23

P577

Q28218404-43C68ABA-FB7A-42C7-A812-C6CF17CEDC1C

P5875

Q28218404-9B7B2AE4-A71D-40AC-AE83-CC13B3D82884

P698

Q28218404-37CFFBCF-830B-4125-B45A-F7555B89CDD4

P932

Q28218404-30CECDAC-8684-4AA4-ADFE-B873608900C6

P356

YMJ.2005.46.1.78

P1433

Yonsei Medical Journal

P1476

Serum levels of advanced glyca ...... estenosis in diabetic patients

@en

P2093

Dongsoo Kim

http://www.w3.org/2001/XMLSchema#string

Geun Taek Lee

http://www.w3.org/2001/XMLSchema#string

Hyuck Moon Kwon

http://www.w3.org/2001/XMLSchema#string

Hyun-Seung Kim

http://www.w3.org/2001/XMLSchema#string

Ki-Hyun Byun

http://www.w3.org/2001/XMLSchema#string

Se-Jung Yoon

http://www.w3.org/2001/XMLSchema#string

Sung Woo Kwon

http://www.w3.org/2001/XMLSchema#string

Sung-Ju Lee

http://www.w3.org/2001/XMLSchema#string

Tae Soo Kang

http://www.w3.org/2001/XMLSchema#string

Young Won Yoon

http://www.w3.org/2001/XMLSchema#string

P2860

3-Deoxyglucosone: metabolism, analysis, biological activity, and clinical implication.

Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications.

Glycation, inflammation, and RAGE: a scaffold for the macrovascular complications of diabetes and beyond.

Central role of RAGE-dependent neointimal expansion in arterial restenosis.

Intensive diabetes therapy and carotid intima-media thickness in type 1 diabetes mellitus

Diabetes and cardiovascular disease. The Framingham study.

Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease. Implications for patient selection. Multivessel Angioplasty Prognosis Study Group.

Plasma 3-deoxyglucosone elevation in chronic renal failure is associated with increased aldose reductase in erythrocytes.

Receptor for AGE (RAGE) mediates neointimal formation in response to arterial injury.

Altered cellular interactions between endothelial cells and nonenzymatically glucosylated laminin/type IV collagen.

P304

78-85

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3349/YMJ.2005.46.1.78

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

46

http://www.w3.org/2001/XMLSchema#string

P50

P577

2005-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7988908

http://www.w3.org/2001/XMLSchema#string

P698

15744809

http://www.w3.org/2001/XMLSchema#string

P932

2823061

http://www.w3.org/2001/XMLSchema#string